Can CoRegen’s CRG-150 turn regulatory T cells into a solid tumour weapon?
Find out how CoRegen is advancing CRG-150 into human trials for metastatic breast cancer, prostate cancer and solid tumours.
Pharma & Biotech
Find out how CoRegen is advancing CRG-150 into human trials for metastatic breast cancer, prostate cancer and solid tumours.